Related Experiment Videos
Flow and image cytometric DNA analysis in rhabdomyosarcoma
A Kowal-Vern1, F Gonzalez-Crussi, J Turner
1Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
Cancer Research
|September 15, 1990
Summary
DNA content in childhood rhabdomyosarcoma did not predict patient outcomes. Tumor stage, not DNA ploidy, correlated with clinical course, suggesting stage is a more critical prognostic factor.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Molecular Pathology
Background:
- Rhabdomyosarcoma is the most common pediatric soft-tissue sarcoma.
- Prognostic significance of DNA content is established in various cancers.
- The role of DNA content in rhabdomyosarcoma prognosis requires further elucidation.
Purpose of the Study:
- To investigate the correlation between DNA content and prognosis in rhabdomyosarcoma.
- To assess the utility of DNA ploidy as a prognostic marker in pediatric rhabdomyosarcoma.
Main Methods:
- Retrospective analysis of 23 rhabdomyosarcoma tumor samples (18 primary, 5 recurrent).
- DNA content analysis using flow cytometry and image cytometry on paraffin-embedded tissue.
- Correlation of DNA content with histology, clinical stage, and patient outcomes.
Main Results:
- Aneuploidy was observed in 10 of 12 embryonal rhabdomyosarcomas (83%), associated with higher recurrence rates (33%).
- DNA content correlated with clinical stage but not with patient's clinical course or histopathological type.
- Flow and image cytometry showed 83% concordance for DNA content analysis.
Conclusions:
- Tumor DNA content in rhabdomyosarcoma did not demonstrate prognostic value for patient outcomes.
- Clinical stage appears to be a more significant prognostic indicator than DNA content in rhabdomyosarcoma.
- Further research may explore other genetic markers for improved rhabdomyosarcoma prognostication.